This is a scientific research study that will look at how a "closed-loop" system and the drug
Pramlintide may work together to improve blood sugar control in people with type 1 diabetes
mellitus. Pramlintide is approved by the Food and Drug Administration (FDA) and is given as
an injection (subcutaneous) that works with insulin to lower blood sugar.